Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Alzheimer's Disease

Alzheimer's: New Treatments But No Prevention Strategy

14 years, 3 months ago

1487  0
Posted on Jan 24, 2005, 4 a.m. By Bill Freeman

While we hear that the Johnson & Johnson Alzheimer's drug Reminyl is associated with higher death rates than placebo, a new "scientific breakthrough" is already in the pipeline. By removing plaques in the brains of mice, which in humans are normally associated with Alzheimer's disease, it seems that some of the nerve damage which is characteristic of the disease, may have been reverted as well.
While we hear that the Johnson & Johnson Alzheimer's drug Reminyl is associated with higher death rates than placebo, a new "scientific breakthrough" is already in the pipeline. By removing plaques in the brains of mice, which in humans are normally associated with Alzheimer's disease, it seems that some of the nerve damage which is characteristic of the disease, may have been reverted as well. Researchers at Washington University School of Medicine are claiming as much, as recently reported by BBC. Alzheimer's is a largely age-dependent disease. According to the same BBC article, it is estimated that 2% to 5% of people over 65 years of age and up to...
http://www.newmediaexplorer.org/sepp/2005/01/24/alzheimers_new_treatments_but_no_prevention_strategy.htm

Subscribe to our Newsletter

WorldHealth Videos

WorldHealth Sponsors